1. Home
  2. Products
  3. Therapeutic Peptides
  4. Peptide Inhibitors

Peptide Inhibitors

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CAT# Product Name M.W Molecular Formula Inquiry
R2196 Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2.TFA 1778.9 C79H110F3N21O21S
R2197 Semaglutide Acetate 4174 C189H295N45O61
R2198 Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA 688.7 C28H39F3N8O9
R2199 L-Glutamine 7-amido-4-methylcoumarin hydrobromide 384.22 C15H18BrN3O4
R2200 RAD16-I hydrochloride 1749.2 C66H114ClN29O25
R2201 Polymyxin B nonapeptide TFA 1533.3 C53H79F15N14O21
R2202 J-2156 TFA 582.6 C26H29F3N4O6S
R2203 D-Ala-Lys-AMCA hydrochloride 468.9 C21H29ClN4O6
R2204 Pal-Gly-His-Lys-OH trifluoroacetate 692.8 C32H55F3N6O7
R2205 Substance P(1-7) (TFA) 1014.1 C43H66F3N13O12
R2206 Biotinoyl-Tripeptide-1 trifluoroacetate 680.7 C26H39F3N8O8S
R2207 PHI 27 (human) trifluoroacetate 3099.4 C137H215F3N34O42S
R2208 Lactoferrin acetate 3183.8 C143H228N46O31S3
R2209 Semax acetate(free base) 874 C39H55N9O12S
R2210 Gamma-glutamylcysteine (TFA) 364.3 C10H15F3N2O7S
R2211 Ac-Arg-Ala-Asp-Ala-Arg-Ala-Asp-Ala-Arg-Ala-Asp-Ala-Arg-Ala-Asp-Ala-NH2 1712.8 C66H113N29O25
R2212 L-tyrosylglycylglycyl-L-phenylalanyl-L-methionyl-L-threonyl-L-seryl-L-alpha-glutamyl-L-lysyl-L-seryl-L-glutaminyl-L-threonyl-L-prolyl-L-leucyl-L-valyl-L-threonyl-L-leucyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-alanyl-L-isoleucyl-L-isoleucyl-L-lysyl-L-asparaginyl-L-valyl-L-histidyl-L-lysyl-L-lysylglycyl-L-glutamine 3466 C157H254N42O44S
R2213 Mif-1 (tfa) 398.38 C15H25F3N4O5
R2214 Brevianamide F 283.32 C16H17N3O2
R2215 Cyclo(-RGDfK) Trifluoroacetate 717.7 C29H42F3N9O9